AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 251 filers reported holding AVANOS MED INC in Q3 2023. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $345 | -21.1% | 17,100 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $437 | -81.7% | 17,100 | -78.7% | 0.00% | -50.0% |
| Q1 2023 | $2,391 | +344.4% | 80,400 | +304.0% | 0.00% | +100.0% |
| Q4 2022 | $538 | -99.9% | 19,900 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $433,000 | -20.4% | 19,900 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $544,000 | -13.5% | 19,900 | +5.9% | 0.00% | 0.0% |
| Q1 2022 | $629,000 | -3.4% | 18,800 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $651,000 | +11.1% | 18,800 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $586,000 | -44.6% | 18,800 | -35.4% | 0.00% | -50.0% |
| Q2 2021 | $1,058,000 | +53.1% | 29,100 | +84.2% | 0.00% | +33.3% |
| Q1 2021 | $691,000 | -4.6% | 15,800 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $724,000 | -32.8% | 15,800 | -36.0% | 0.00% | -40.0% |
| Q2 2019 | $1,077,000 | -0.2% | 24,700 | -2.4% | 0.01% | 0.0% |
| Q1 2019 | $1,079,000 | +4.4% | 25,300 | +9.5% | 0.01% | 0.0% |
| Q4 2018 | $1,034,000 | -29.8% | 23,100 | +7.4% | 0.01% | -16.7% |
| Q3 2018 | $1,472,000 | – | 21,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
| RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
| Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
| HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
| WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
| Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
| Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
| J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
| Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |